InvestSMART

Cryosite Limited (ASX:CTE)

ALERT: Price-sensitive ASX Announcement for CTE
Current share price for CTE : $1.150 -0.05 (-4.17%)+
Announcement
Release
26 Feb 2026 5:26PM
Price at Release
$1.200
Full Release
download
Summary
Cryosite Limited's Appendix 4D and Half Year Accounts for the period ending 31 December 2025 reflect significant financial growth and operational changes. The company reported a revenue increase to $8.273 million, marking a 25% growth from the previous period. The Ultra-Frozen and Cryogenic segment emerged as a key growth driver, with revenue up by 63%. The report highlights strong operating cash flows and the acquisition of a new warehouse property to support future expansion. Although no interim dividend was declared, the company emphasized reinvesting in high-return opportunities. The directors expressed confidence in the company's ability to meet future obligations and continue its growth trajectory.
Key Points
  • Revenue increased by 25% to $8.273 million.
  • Ultra-Frozen and Cryogenic segment revenue grew by 63%.
  • Net profit after tax increased by 36% to $1.138 million.
  • Acquisition of a new warehouse property for $10.1 million.
  • Strong operating cash flows and facility refinancing plans.
  • No interim dividend declared; focus on reinvestment.
  • Directors express confidence in meeting future obligations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.